2018 Treatment Algorithm for Breast Ca
The ASCO Post,
Advertisement How should clinicians position anti-HER2 agents and also incorporate endocrine therapies in the treatment of…
Advertisement How should clinicians position anti-HER2 agents and also incorporate endocrine therapies in the treatment of…
Advertisement Karen Lisa Smith, MD, MPH Vered Stearns, MD The fact that a new guideline for the management of advanced HER2-posit…
As many as half of all patients with metastatic HER2-positive breast cancer develop brain metastases over time. The American…
Approximately 20% of all breast cancers are human epidermal growth factor receptor 2 (HER2)-positive. Prior to the era of HER2-ta…